BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 8675695)

  • 1. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures.
    Williams LM; Gibbons DL; Gearing A; Maini RN; Feldmann M; Brennan FM
    J Clin Invest; 1996 Jun; 97(12):2833-41. PubMed ID: 8675695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells.
    Gallea-Robache S; Morand V; Millet S; Bruneau JM; Bhatnagar N; Chouaib S; Roman-Roman S
    Cytokine; 1997 May; 9(5):340-6. PubMed ID: 9195133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints.
    Brennan FM; Gibbons DL; Mitchell T; Cope AP; Maini RN; Feldmann M
    Eur J Immunol; 1992 Jul; 22(7):1907-12. PubMed ID: 1320571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes.
    Joyce DA; Gibbons DP; Green P; Steer JH; Feldmann M; Brennan FM
    Eur J Immunol; 1994 Nov; 24(11):2699-705. PubMed ID: 7957562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p55 and p75 tumor necrosis factor receptors are expressed and mediate common functions in synovial fibroblasts and other fibroblasts.
    Butler DM; Feldmann M; Di Padova F; Brennan FM
    Eur Cytokine Netw; 1994; 5(5):441-8. PubMed ID: 7880974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor.
    Müllberg J; Durie FH; Otten-Evans C; Alderson MR; Rose-John S; Cosman D; Black RA; Mohler KM
    J Immunol; 1995 Dec; 155(11):5198-205. PubMed ID: 7594530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha promotes the expression of osteoprotegerin in rheumatoid synovial fibroblasts.
    Kubota A; Hasegawa K; Suguro T; Koshihara Y
    J Rheumatol; 2004 Mar; 31(3):426-35. PubMed ID: 14994384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of antigen-presenting cell function and stimulation of human peripheral blood mononuclear cells to express an antiinflammatory cytokine profile by the stress protein BiP: relevance to the treatment of inflammatory arthritis.
    Corrigall VM; Bodman-Smith MD; Brunst M; Cornell H; Panayi GS
    Arthritis Rheum; 2004 Apr; 50(4):1164-71. PubMed ID: 15077298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibronectin-bound TNF-alpha stimulates monocyte matrix metalloproteinase-9 expression and regulates chemotaxis.
    Vaday GG; Hershkoviz R; Rahat MA; Lahat N; Cahalon L; Lider O
    J Leukoc Biol; 2000 Nov; 68(5):737-47. PubMed ID: 11073115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist.
    Butler DM; Maini RN; Feldmann M; Brennan FM
    Eur Cytokine Netw; 1995; 6(4):225-30. PubMed ID: 8789287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Soluble TNF p55 and p75 receptors in the development of sepsis syndrome].
    Modzelewski B
    Pol Merkur Lekarski; 2003 Jan; 14(79):69-72. PubMed ID: 12712835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic matrix metalloproteinase inhibitors and tissue inhibitor of metalloproteinase (TIMP)-2, but not TIMP-1, inhibit shedding of tumor necrosis factor-alpha receptors in a human colon adenocarcinoma (Colo 205) cell line.
    Lombard MA; Wallace TL; Kubicek MF; Petzold GL; Mitchell MA; Hendges SK; Wilks JW
    Cancer Res; 1998 Sep; 58(17):4001-7. PubMed ID: 9731514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55.
    Alsalameh S; Amin RJ; Kunisch E; Jasin HE; Kinne RW
    J Rheumatol; 2003 Aug; 30(8):1680-90. PubMed ID: 12913922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNF-alpha.
    Alaaeddine N; DiBattista JA; Pelletier JP; Cloutier JM; Kiansa K; Dupuis M; Martel-Pelletier J
    J Rheumatol; 1997 Oct; 24(10):1985-94. PubMed ID: 9330943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.
    Xu H; He Y; Yang X; Liang L; Zhan Z; Ye Y; Yang X; Lian F; Sun L
    Rheumatology (Oxford); 2007 Jun; 46(6):920-6. PubMed ID: 17314215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-4, IL-10 and IFN-gamma have distinct, but interacting, effects on differentiation-induced changes in TNF-alpha and TNF receptor release by cultured human monocytes.
    Joyce DA; Steer JH
    Cytokine; 1996 Jan; 8(1):49-57. PubMed ID: 8742066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
    Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
    Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship of hydroxamate-based inhibitors on membrane-bound Fas ligand and TNF-alpha processing.
    Yamamoto M; Hirayama R; Naruse K; Yoshino K; Shimada A; Inoue S; Kayagaki N; Yagita H; Okumura K; Ikeda S
    Drug Des Discov; 1999 Aug; 16(2):119-30. PubMed ID: 10533808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.